Cover Image

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis

Jie Deng,1 Lorne M Golub,2 Hsi-Ming Lee,2 Veena Raja,2 Francis Johnson,3 Allan Kucine,4 Wonsae Lee,5 Tian-Min Xu,1 Ying Gu6 1Department of Orthodontics, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laborator...

Full description

Saved in:

Bibliographic Details
Main Authors:	Deng J (Author), Golub LM (Author), Lee HM (Author), Raja V (Author), Johnson F (Author), Kucine A (Author), Lee W (Author), Xu TM (Author), Gu Y (Author)
Format:	Book
Published:	Dove Medical Press, 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications
by: Wang HH, et al.
Published: (2019)

Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]
by: Wang HH, et al.
Published: (2020)

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
by: Deng J, et al.
Published: (2020)

The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats
by: Bhatt HD, et al.
Published: (2022)

A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations
by: Muna S. Elburki, et al.
Published: (2014)

A Novel Chemically-Modified Curcumin 2.24: Short-Term Systemic Therapy for Natural Periodontitis in Dogs
by: Jie Deng, et al.
Published: (2021)

Effects of curcumin gel on osteoclastogenic bone markers in experimental periodontitis and alveolar bone loss in wistar rats
by: Aram Mohammed Sha, et al.
Published: (2021)

Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
by: Bhatt HD, et al.
Published: (2023)

4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation
by: Ying Gu, et al.
Published: (2013)

Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice
by: Satoshi Deyama, et al.
Published: (2018)

Chronological analysis of periodontal bone loss in experimental periodontitis in mice
by: Cristhiam de J. Hernández Martínez, et al.
Published: (2023)

Resolvin D2 attenuates chronic pain-induced depression‐like behavior in mice
by: Hiroe Suzuki, et al.
Published: (2021)

Role of Resolvins in Inflammatory and Neuropathic Pain
by: Jaeik Park, et al.
Published: (2023)

Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy
by: Xin Luo, et al.
Published: (2019)

The effects of morus nigra on the alveolar bone loss in experimentally-induced periodontitis
by: Gonca Ozan, et al.
Published: (2019)

The effects of morus nigra on the alveolar bone loss in experimentally-induced periodontitis
by: Elif Erdem, et al.
Published: (2019)

Effect of obesity on alveolar bone loss in experimental periodontitis in Wistar rats
by: Giliano Nicolini Verzeletti, et al.
Published: (2012)

Does Chemically Modified Curcumin Control the Progression of Periodontitis? A Systematic Review
by: Dhaifullah E, et al.
Published: (2021)

Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
by: Chunrong Li, et al.
Published: (2020)

Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
by: Sajad Chamani, et al.
Published: (2020)

SAGE: Novel Therapy to Reduce Inflammation in a Naturally Occurring-Dog Model of Periodontal Disease
by: Raja V, et al.
Published: (2022)

Resolvins as potential candidates for the treatment of major depressive disorder
by: Satoshi Deyama, et al.
Published: (2021)

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model
by: Aurigena Antunes de ARAÚJO, et al.
Published: (2019)

Resolvin E1's Antimicrobial Potential Against Aggregatibacter Actinomycetemcomitans
by: Fahad A. Abdullatif, et al.
Published: (2022)

Association of resolvin level in pregnant women with preeclampsia and metabolic syndrome
by: Sabah Farhat, et al.
Published: (2020)

Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
by: John Pirault, et al.
Published: (2018)

Resolvin E1 Inhibits Substance P-Induced Potentiation of TRPV1 in Primary Sensory Neurons
by: Youn Yi Jo, et al.
Published: (2016)

Comparison of two methods for alveolar bone loss measurement in an experimental periodontal disease model in rats
by: Diego Nique Liberman, et al.
Published: (2011)

B-Cell Deficiency Exacerbates Inflammation and Bone Loss in Ligature-Induced Experimental Periodontitis in Mice
by: Zeng W, et al.
Published: (2021)

Polymethoxy Flavonoids, Nobiletin and Tangeretin, Prevent Lipopolysaccharide-Induced Inflammatory Bone Loss in an Experimental Model for Periodontitis
by: Tsukasa Tominari, et al.
Published: (2012)

Bifidobacterium Strains Present Distinct Effects on the Control of Alveolar Bone Loss in a Periodontitis Experimental Model
by: Natali Shimabukuro, et al.
Published: (2021)

Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats
by: Andressa Araújo SWERTS, et al.

Host modulation therapy in periodontitis, diagnosis and treatment-status update
by: Lorne M. Golub, et al.
Published: (2024)

The Effect of the Root Bark of <i>Lycium chinense</i> (Lycii Radicis Cortex) on Experimental Periodontitis and Alveolar Bone Loss in Sprague-Dawley Rats
by: Jinwon Yang, et al.
Published: (2024)

Boric acid inhibits alveolar bone loss in rat experimental periodontitis through diminished bone resorption and enhanced osteoblast formation
by: Nazmus Shalehin, et al.
Published: (2020)

Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?
by: Hesselink JMK, et al.
Published: (2016)

Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1
by: Pier Giorgio Puzzovio, et al.
Published: (2023)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

Resolvin D1 Reduces the Immunoinflammatory Response of the Rat Eye following Uveitis
by: Rossi Settimio, et al.
Published: (2012)

Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats
by: Mehmet SAĞLAM, et al.
Published: (2015)